Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen
出版年份 2015 全文链接
标题
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen
作者
关键词
-
出版物
BRITISH JOURNAL OF HAEMATOLOGY
Volume 172, Issue 1, Pages 111-121
出版商
Wiley
发表日期
2015-10-13
DOI
10.1111/bjh.13803
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma†
- (2014) A. S. Gerrie et al. ANNALS OF ONCOLOGY
- Brentuximab vedotin
- (2014) S. M. Ansell BLOOD
- Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma
- (2014) G. Visani et al. BLOOD
- Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all!
- (2014) M A Kharfan-Dabaja et al. BONE MARROW TRANSPLANTATION
- High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed or refractory Hodgkin lymphoma: A systematic review with meta-analysis
- (2014) Michaela Rancea et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Stem Cell Transplantation in Hodgkin Lymphoma
- (2014) Nishitha M. Reddy et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation†
- (2013) C. Martínez et al. ANNALS OF ONCOLOGY
- Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin’s lymphoma: outcome after high-dose chemotherapy and auto-SCT
- (2013) S Akhtar et al. BONE MARROW TRANSPLANTATION
- New drugs and targeted treatments in Hodgkin’s lymphoma
- (2013) Mariano Provencio et al. CANCER TREATMENT REVIEWS
- Impact of Conditioning Regimen on Outcome of 2-Year Disease-Free Survivors of Autologous Stem Cell Transplantation for Hodgkin Lymphoma
- (2013) Basem M. William et al. Clinical Lymphoma Myeloma & Leukemia
- Relapsed/Refractory Hodgkin Lymphoma
- (2013) Mark Hertzberg HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study
- (2013) Anas Younes et al. LANCET ONCOLOGY
- Improved outcome with busulfan, melphalan and thiotepa conditioning in autologous hematopoietic stem cell transplant for relapsed/refractory Hodgkin lymphoma
- (2013) Tarunpreet Bains et al. LEUKEMIA & LYMPHOMA
- Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphoma
- (2013) Stephanie Sasse et al. LEUKEMIA & LYMPHOMA
- Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome
- (2012) Yago Nieto et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The role of hematopoietic stem cell transplantation in the treatment of relapsed/refractory Hodgkinʼs lymphoma
- (2012) Anna Sureda et al. CURRENT OPINION IN ONCOLOGY
- Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy
- (2012) R. Devillier et al. HAEMATOLOGICA
- BCNU-associated pneumonitis: portrait of a toxicity
- (2012) Brian G. Till et al. LEUKEMIA & LYMPHOMA
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- The emerging role of PET in Hodgkin lymphoma patients receiving autologous stem cell transplant
- (2012) Bastian von Tresckow et al. Expert Review of Hematology
- Prognostic Significance of FDG-PET in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Standard Salvage Chemotherapy and Autologous Stem Cell Transplantation
- (2011) Jacob P. Smeltzer et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma
- (2011) C. H. Moskowitz et al. BLOOD
- Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres
- (2011) Stephen D. Smith et al. BRITISH JOURNAL OF HAEMATOLOGY
- Predictive Factors for Radiation Pneumonitis in Hodgkin Lymphoma Patients Receiving Combined-Modality Therapy
- (2011) Amy M. Fox et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Pre-transplant positron emission tomography/computed tomography (PET/CT) in relapsed Hodgkin lymphoma: time to shift gears for PET-positive patients?
- (2011) Martin Hutchings LEUKEMIA & LYMPHOMA
- Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study
- (2009) M Musso et al. BONE MARROW TRANSPLANTATION
- Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma
- (2009) Navneet S. Majhail et al. BRITISH JOURNAL OF HAEMATOLOGY
- Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma
- (2008) B. Sirohi et al. ANNALS OF ONCOLOGY
- Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group
- (2008) Nicole Blijlevens et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started